Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Strata Skin Sciences ( (SSKN) ) just unveiled an update.
On August 19, 2025, Strata Skin Sciences received a notice from Nasdaq indicating non-compliance with the minimum stockholders’ equity requirement for continued listing on the Nasdaq Capital Market. The company has until October 3, 2025, to submit a compliance plan, with the possibility of a 180-day extension if accepted. The notice does not immediately affect the company’s stock listing, but failure to comply could lead to delisting, although the company can appeal such a decision.
The most recent analyst rating on (SSKN) stock is a Hold with a $1.50 price target. To see the full list of analyst forecasts on Strata Skin Sciences stock, see the SSKN Stock Forecast page.
Spark’s Take on SSKN Stock
According to Spark, TipRanks’ AI Analyst, SSKN is a Neutral.
Strata Skin Sciences faces significant financial and operational challenges, reflected in its low financial performance and valuation scores. While there are promising strategic initiatives and potential market expansions, the current bearish technical indicators and ongoing losses weigh heavily on the overall stock score.
To see Spark’s full report on SSKN stock, click here.
More about Strata Skin Sciences
Strata Skin Sciences, Inc. operates in the medical technology industry, focusing on dermatological treatments. The company is known for its products and services that cater to skin health and treatment solutions.
Average Trading Volume: 24,654
Technical Sentiment Signal: Sell
Current Market Cap: $7.63M
For detailed information about SSKN stock, go to TipRanks’ Stock Analysis page.